The Oncology Institute, Inc. TOI Derivative warrant liabilities
Derivative warrant liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept toi:DerivativeWarrantLiabilitiesNoncurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s derivative warrant liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s derivative warrant liabilities?
- The Oncology Institute, Inc. (TOI) reported derivative warrant liabilities of $96K in Q1 2026.
- How has The Oncology Institute, Inc.'s derivative warrant liabilities changed year-over-year?
- The Oncology Institute, Inc.'s derivative warrant liabilities increased by 62.7% year-over-year, from $59K to $96K.
- What does derivative warrant liabilities mean?
- This represents the fair value of outstanding warrants issued by the company that are classified as liabilities rather than equity. These instruments often arise from financing activities and are subject to periodic revaluation based on changes in the company's stock price and volatility. Monitoring this balance is essential for understanding potential future dilution and the impact of market fluctuations on the company's balance sheet.